Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells
- PMID: 19269301
- DOI: 10.1016/j.taap.2009.02.020
Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells
Abstract
Primary cells are ideal for in vitro toxicity studies since they closely resemble tissue environment. Here, we report a detailed study on the in vitro interactions of 7-20 nm spherical silver nanoparticles (SNP) with primary fibroblasts and primary liver cells isolated from Swiss albino mice. The intended use of silver nanoparticles is in the form of a topical antimicrobial gel formulation for the treatment of burns and wounds. Upon exposure to SNP for 24 h, morphology of primary fibroblasts and primary liver cells remained unaltered up to 25 microg/mL and 100 microg/mL SNP, respectively, although with minor decrease in confluence. IC(50) values for primary fibroblasts and primary liver cells as revealed by XTT assay were 61 microg/mL and 449 microg/mL, respectively. Ultra-thin sections of primary cells exposed to 1/2 IC(50) SNP for 24 h, visualized under Transmission electron microscope showed the presence of dark, electron dense, spherical aggregates inside the mitochondria, and cytoplasm, probably representing the intracellular SNP. When the cells were challenged with approximately 1/2 IC(50) concentration of SNP (i.e. 30 microg/mL and 225 microg/mL for primary fibroblasts and primary liver cells, respectively), enhancement of GSH (approximately 1.2 fold) and depletion of lipid peroxidation (approximately 1.4 fold) were seen in primary fibroblasts which probably protect the cells from functional damage. In case of primary liver cells; increased levels of SOD ( approximately 1.4 fold) and GSH ( approximately 1.1 fold) as compared to unexposed cells were observed. Caspase-3 activity assay indicated that the SNP concentrations required for the onset of apoptosis were found to be much lower (3.12 microg/mL in primary fibroblasts, 12.5 microg/mL in primary liver cells) than the necrotic concentration (100 microg/mL in primary fibroblasts, 500 microg/mL in primary liver cells). These observations were confirmed by CLSM studies by exposure of cells to 1/2 IC(50) SNP (resulting in apoptosis) and 2 x IC(50)) cells (resulting in necrosis). These results clearly suggest that although silver nanoparticles seem to enter the eukaryotic cells, cellular antioxidant mechanisms protect the cells from possible oxidative damage. This property, in conjunction with the finding that primary cells possess much higher SNP tolerance than the concentration in the gel (approximately 20 microg/g), indicates preliminary safety of the formulation and warrants further study for possible human application.
Similar articles
-
Cellular responses induced by silver nanoparticles: In vitro studies.Toxicol Lett. 2008 Jun 30;179(2):93-100. doi: 10.1016/j.toxlet.2008.04.009. Epub 2008 Apr 25. Toxicol Lett. 2008. PMID: 18508209
-
Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.Mol Pharm. 2009 Sep-Oct;6(5):1388-401. doi: 10.1021/mp900056g. Mol Pharm. 2009. PMID: 19473014
-
Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster.Toxicol Appl Pharmacol. 2010 Feb 1;242(3):263-9. doi: 10.1016/j.taap.2009.10.016. Epub 2009 Oct 27. Toxicol Appl Pharmacol. 2010. PMID: 19874832
-
[Status of biological evaluation on silver nanoparticles].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Aug;25(4):958-61. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008. PMID: 18788318 Review. Chinese.
-
[Maintenance of a glutathione level in mammalian cells].Tanpakushitsu Kakusan Koso. 1988 Jul;33(9):1442-9. Tanpakushitsu Kakusan Koso. 1988. PMID: 3074365 Review. Japanese. No abstract available.
Cited by
-
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.Nanomedicine. 2014 Jan;10(1):1-9. doi: 10.1016/j.nano.2013.06.010. Epub 2013 Jun 28. Nanomedicine. 2014. PMID: 23811290 Free PMC article. Clinical Trial.
-
A systematic review on silver nanoparticles-induced cytotoxicity: Physicochemical properties and perspectives.J Adv Res. 2017 Nov 2;9:1-16. doi: 10.1016/j.jare.2017.10.008. eCollection 2018 Jan. J Adv Res. 2017. PMID: 30046482 Free PMC article. Review.
-
Microcellular Environmental Regulation of Silver Nanoparticles in Cancer Therapy: A Critical Review.Cancers (Basel). 2020 Mar 12;12(3):664. doi: 10.3390/cancers12030664. Cancers (Basel). 2020. PMID: 32178476 Free PMC article. Review.
-
Toxicity Effect of Silver Nanoparticles on Mice Liver Primary Cell Culture and HepG2 Cell Line.Iran J Pharm Res. 2014 Winter;13(1):235-42. Iran J Pharm Res. 2014. PMID: 24734076 Free PMC article.
-
Redox-active nanomaterials for nanomedicine applications.Nanoscale. 2017 Oct 19;9(40):15226-15251. doi: 10.1039/c7nr05429g. Nanoscale. 2017. PMID: 28991962 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials